<!DOCTYPE html>
<html lang="en">
<head>
<?php $id='1759-490'; include '../../seo.php';?>
<?php include '../../side-nav.php';?>
<div class="page-content">
<!--section-->
<div class="section mt-0">
<div class="breadcrumbs-wrap">
<div class="container">
<div class="breadcrumbs">
<a href="https://sprintdiagnostics.in/">Home</a>
<a href="https://www.sprintdiagnostics.in/hyderabad/profile/">Profile</a>
<span>Autoimmune Hepatitis Panel I (ANA-IFA with titers, AMA- IFA, ANCA-IFA withtiters, ASMA -IFA, Anti LKM) </span>
</div>
</div>
</div>
</div>
<!--//section-->
<!--section-->
<div class="section page-content-first">
<div class="container mt-6">
<div class="row">
<div class="col-md-8 col-lg-8 mt-0 mt-md-0 mb-4">
<h1 class="test-h1">Autoimmune Hepatitis Panel I (ANA-IFA with titers, AMA- IFA, ANCA-IFA withtiters, ASMA -IFA, Anti LKM) </h1>
<div class="post-text">
<p>Autoimmune Hepatitis Panel I plays an instrumental role in the diagnosis and management of
autoimmune hepatitis, a condition where the body's immune system attacks liver cells, causing
inflammation and liver damage. This comprehensive panel detects a range of antibodies using an
immunofluorescence assay (IFA) to provide key insights into the disease and guide treatment strategies.
Understanding the intricacies of this diagnostic test can help patients and healthcare professionals
navigate the path to optimal liver health. </p>
<p>The Autoimmune Hepatitis Panel I utilizes an IFA to identify several types of antibodies present in the
blood, which can signify different aspects of autoimmune hepatitis. The panel includes antinuclear
antibodies (ANA), anti-mitochondrial antibodies (AMA), antineutrophil cytoplasmic antibodies (ANCA),
anti-smooth muscle antibodies (ASMA), and anti-liver kidney microsomal type 1 antibodies (Anti-LKM1). </p>
<p>Autoimmune hepatitis can be classified into different types based on the presence of these antibodies.
Type 1 autoimmune hepatitis, the most common form, is typically associated with ANA, ASMA, and at
times, ANCA. Type 2 autoimmune hepatitis, on the other hand, is identified by the presence of Anti-
LKM1 antibodies. Although AMA antibodies are usually linked with primary biliary cirrhosis, they can
also be seen in autoimmune hepatitis. The detection and quantification of these antibodies through the
Autoimmune Hepatitis Panel I, therefore, contribute to a more precise diagnosis, providing the basis for
targeted treatment.</p>
<div class="table-wrap">
<table class="table table-striped">
	<thead>
		<tr>
			<th scope="col">Profile Name</th>
			<td scope="col">Autoimmune Hepatitis Panel I (ANA-IFA with titers, AMA- IFA, ANCA-IFA withtiters, ASMA -IFA, Anti LKM) </td>
		</tr>
	</thead>
	<tbody>
		<tr>
			<th scope="row">Sample Type</th>
			<td>Blood </td>
		</tr>
		<tr>
			<th scope="row">Preparations Required</th>
			<td> No specific instructions are necessary for this test</td>
		</tr>
		<tr>
			<th scope="row">Report Time</th>
			<td> refer individual tests</td>
		</tr>
		<tr>
			<th scope="row">Price in Hyderabad</th>
			<td>â‚¹  6900</td>
		</tr>
	</tbody>
</table>
</div>
<div class="post-text">
<h2 class="test-h2 mt-3"> Why is the Autoimmune Hepatitis Panel I ordered?</h2>
	<p>
The Autoimmune Hepatitis Panel I is ordered when a patient presents with signs or symptoms
suggestive of liver disease, such as jaundice, fatigue, abdominal discomfort, or abnormal liver function
tests, and autoimmune hepatitis is suspected.</p>
<h2 class="test-h2 mt-3"> What does the presence of specific antibodies mean?</h2>
<p>
The presence of specific antibodies can indicate different types of autoimmune hepatitis. For example,
ANA and ASMA are usually associated with type 1 autoimmune hepatitis, while Anti-LKM1 is related to
type 2.</p>
	<!--section achieved-->
	<?php include "../../include/iconsbox.php" ?>
	<!--//section achieved-->
	
<h2 class="test-h2 mt-3"> Do I need to fast before this test?</h2>
<p>

No, fasting is not required before the Autoimmune Hepatitis Panel I. You can eat and drink as you
usually would.</p>
<h2 class="test-h2 mt-3"> What method is used for the Autoimmune Hepatitis Panel I?</h2>
<p>
The panel employs an immunofluorescence assay (IFA), a laboratory technique used to detect the
presence of specific antibodies in the blood.</p>
<h2 class="test-h2 mt-3"> What treatment options are available for autoimmune hepatitis?</h2>
<p>
Autoimmune hepatitis is typically managed with medications to suppress the immune system and
reduce inflammation in the liver. These may include corticosteroids and immunosuppressive drugs. Your
doctor will determine the best treatment plan based on your specific condition and overall health.</p>
<h2 class="test-h2 mt-3"> Can other conditions affect the test results?</h2>
<p>
Yes, other conditions such as viral hepatitis, primary biliary cirrhosis, or drug-induced liver injury can
affect the results of the Autoimmune Hepatitis Panel I. Always inform your doctor of any existing
conditions and medications you are taking.</p>
<h2 class="test-h2 mt-3"> What happens if my test results are abnormal?</h2>
<p>
Abnormal results may indicate autoimmune hepatitis, but further tests will be necessary to confirm the
diagnosis. If the results are abnormal, your doctor will likely order more specific tests or refer you to a
gastroenterologist or hepatologist for further evaluation and treatment.</p>
<h2 class="test-h2 mt-3"> How often should I get this test done?</h2>
<p>
If you have been diagnosed with autoimmune hepatitis, your doctor will determine how often you
should get this test done based on your condition's progression and your response to treatment.</p>
<h2 class="test-h2 mt-3"> Can this test be done at home?</h2>
<p>
No, the Autoimmune Hepatitis Panel I requires a blood sample to be taken by a healthcare professional,
and the analysis should be performed in a laboratory.</p>
<h2 class="test-h2 mt-3"> Can this test diagnose other liver diseases?</h2>
<p>
While the Autoimmune Hepatitis Panel I is specifically designed to aid in the diagnosis of autoimmune
hepatitis, abnormal results can suggest other liver diseases. Your doctor will interpret the results in the
context of your symptoms and other test results.</p>
<p>The diagnosis and management of autoimmune hepatitis can be complex, but advances in testing, such
as the Autoimmune Hepatitis Panel I, have significantly enhanced our ability to identify and treat this
condition. Early diagnosis and timely treatment can help to control the disease and prevent severe liver
damage. Therefore, it is crucial to discuss any concerns with your doctor and get tested if autoimmune
hepatitis is suspected. Staying informed and proactive in your health care journey is key to maintaining
optimal liver health.</p>
	
</div>		
</div>			
</div>
<!--form section-->
<?php include "../../include/bookslot.php" ?>
<!--form section-->
</div>
</div>
<!--//section-->
</div>
</div>
<?php include '../../footer.php';?>
</body>
</html>